|
|
| | FMOC-T-BUTYL-L-ALANINE Basic information |
| Product Name: | FMOC-T-BUTYL-L-ALANINE | | Synonyms: | FMOC-LEU(ME)-OH;FMoc-b-tBu-Ala-OH;(S)-2-((((9H-Fluoren-9-yl)Methoxy)carbonyl)aMino)-4,4-diMethylpentanoic acid;(S)-2-((((9H-Fluoren-9-yl)Methoxy)carbonyl)(tert-butyl)aMino)propanoic acid;Fmoc-b-tBu-Ala-OH·HCl;Fmoc-beta-t-butyl-L-alanine;Fmoc-b-t-butyl-L-alanine;N-[(9H-Fluoren-9-ylmethoxy)carbonyl]-4-methyl-L-leucine | | CAS: | 139551-74-9 | | MF: | C22H25NO4 | | MW: | 367.44 | | EINECS: | | | Product Categories: | | | Mol File: | 139551-74-9.mol |  |
| | FMOC-T-BUTYL-L-ALANINE Chemical Properties |
| Boiling point | 562.7±33.0 °C(Predicted) | | density | 1.189±0.06 g/cm3 (20 ºC 760 Torr) | | storage temp. | 2-8°C | | pka | 3.92±0.23(Predicted) |
| Safety Statements | 24/25 | | HazardClass | IRRITANT | | HS Code | 29225090 |
| | FMOC-T-BUTYL-L-ALANINE Usage And Synthesis |
| Uses | Fmoc-t-butyl-L-alanine is used in the synthesis arylaminoethyl amides as noncovalent inhibitors of cathepsin S. It is also an intermediate used to prepare oxamyl dipeptide caspase inhibitors developed for the treatment of stroke. |
| | FMOC-T-BUTYL-L-ALANINE Preparation Products And Raw materials |
|